Jonathan Medved, CEO of the Jerusalem-based global investment platform OurCrowd, told The Media Line that the outbreak had shifted the focus of many investors in a way that could have far-reaching implications for medical innovation.
Read more here.
Jonathan Medved, CEO of the Jerusalem-based global investment platform OurCrowd, told The Media Line that the outbreak had shifted the focus of many investors in a way that could have far-reaching implications for medical innovation.
Read more here.
![[OurCrowd CEO Jon Medved on i24NEWS] OurCrowd to raise $100M for COVID-19 tech](https://blog.mktg.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
